By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Boston Biomedical 

640 Memorial Drive

Cambridge  Massachusetts  02139  U.S.A.
Phone: 617-674-8600 Fax: 781-762-9863


SEARCH JOBS


Industry
Biotechnology

Segment
Start Up





Company News
Boston Biomedical Announces First Clinical Data For Investigational WT1 Cancer Peptide Vaccine, DSP-7888, At American Society of Hematology Annual Meeting & Exposition 12/6/2016 10:46:35 AM
Boston Biomedical Announces Orphan Drug Designation For Napabucasin In Pancreatic Cancer 11/14/2016 6:27:53 AM
Boston Biomedical Initiates Canstem303c: A Global Phase III Study Investigating Cancer Stemness Inhibitor Napabucasin In Patients With Pretreated Advanced Colorectal Cancer 10/21/2016 6:48:19 AM
Boston Biomedical Announces First Orphan Drug Designation For Napabucasin In Gastric/GEJ Cancer 6/23/2016 8:22:05 AM
ASCO2016: Boston Biomedical Featured Seven Clinical Posters On Cancer Stem Cell Pathway Inhibitors Napabucasin And Amcasertib In Multiple Cancer Types At ASCO 2016 6/8/2016 7:46:01 AM
Boston Biomedical Announces Clinical Data On First-In-Class Investigational Cancer Stem Cell Pathway Inhibitors Napabucasin And Amcasertib In Multiple Cancer Types At ASCO 2016 5/19/2016 7:39:45 AM
Boston Biomedical Partners With CardioFocus In Premarket Approval Of Heartlight System 4/14/2016 8:08:51 AM
Boston Biomedical's Investigational Cancer Stem Cell Pathway Inhibitor, Napabucasin (BBI608), Featured At The ASCO 2016 Gastrointestinal Cancers Symposium 1/25/2016 6:20:58 AM
Boston Biomedical To Highlight Data Examining Novel Investigational Cancer Stem Cell Pathway Inhibitors BBI608 And BBI503 In Multiple Cancer Types At ASCO 2015 5/14/2015 3:10:10 PM
Boston Biomedical Announces Senior Management Appointments 9/10/2014 10:13:20 AM
12
//-->